Out of thirty-seven studies, thirteen focussed on levodopa induced dyskinesia exclusively, three on other motor fluctuation exclusively, one on wearing on/off, three on hyper-homocysteinemia, five studies were on hallucination, one study each on COMT inhibitor induced toxicity and elevated liver transaminase levels, and twelve studies discussed multiple ADR in the same cohort of recruited patients. The gene discussed is COMT; the disease is Dyskinesia.